Aligos Therapeutics (ALGS)
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Galectin Therapeutics Inc. (GALT)
Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update
Nano X Imaging Ltd (NNOX)
Nanox Partners with French Radiology Group Olympe Imagerie to Advance Clinical Validation in Europe
bioAffinity Technologies Inc. (BIAF)
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
Sensus Healthcare Inc (SRTS)
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
bioAffinity Technologies Inc. (BIAFW)
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
Purple Biotech Ltd. (PPBT)
Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update
Alkermes plc (ALKS)
Alkermes Response to Avadel Announcement
Zimmer Biomet Holdings Inc (ZBH)
Zimmer Biomet Holdings, Inc. Notification
Anavex Life Sciences Corp. (AVXL)
Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimers Disease